Sanofi (France)
NEWS
It was a busy week for clinical trial updates for the first week of November. Here’s a look.
It was the first randomized, controlled trial comparing Toujeo to Gla-100 in this patient population.
The digital-enabled aspect of the manufacturing plant is designed to leverage better use of data to optimize manufacturing processes and increase efficiencies.
GlobalData recently published their top 20 global pharma companies categorized by market capitalization in the first quarter of 2019.
BioSpace scanned the WARN (Worker Adjustment and Retraining Notification) notices across the country and compiled a small list of recent layoffs across the industry.
In the wake of the discovery that some Zantac products may contain a carcinogen contaminant due to the manufacturing process, three major drug store retailers in the United States have removed the antacid product from the shelves.
Last week was an unusually busy week for clinical trial news, with numerous companies presenting results at conferences. Here’s a look at the top stories.
The deal had the upside potential of $1.7 billion but showed mixed results in three Phase III clinical trials. Sanofi announced it had terminated the collaboration, but Lexicon lashed out, alleging Sanofi’s termination was “invalid” and the company was “in breach of contract.”
Glioblastoma is very difficult to treat and there have been several recent clinical trial failures for new drugs.
JOBS
IN THE PRESS